{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:33:26Z","timestamp":1791725606949,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970160"],"award-info":[{"award-number":["81970160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800181"],"award-info":[{"award-number":["81800181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570160"],"award-info":[{"award-number":["81570160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100351"],"award-info":[{"award-number":["81100351"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphocyte trafficking via chemokine receptors such as C-C chemokine receptor 5 (CCR5) and CXCR3 plays a critical role in the pathogenesis of acute graft-versus-host disease (aGVHD). Our previous studies showed that the addition of CCR5 or CXCR3 antagonists could only slightly alleviate the development of aGVHD. Given the specificity of T lymphocytes bearing CXCR3 and CCR5, we investigated whether combined CCR5 and CXCR3 blockade could further attenuate murine aGVHD. A mouse model of aGVHD was established to assess the efficacy of CCR5 and\/or CXCR3 blockade on the development of aGVHD. The distribution of lymphocytes was calculated by quantification of immunostaining cells. The immunomodulatory effect on T cells was assessed by evaluating T-cell proliferation, viability, and differentiation. Using the murine allogeneic hematopoietic stem cell transplantation model, we demonstrated that blockade of both CCR5 and CXCR3 could efficiently alleviate the development of aGVHD. Further investigation on the immune mechanisms for this prophylactic effect showed that more T cells were detained into secondary lymphoid organs (SLOs), which may lead to reduced infiltration of T cells into GVHD target organs. Our study also showed that T cells detained in SLOs dampened the activation, suppressed the polarization toward T helper type 1 (Th1) and T cytotoxic type 1 (Tc1) cells, and induced the production of Treg cells. These data suggest that concurrent blockade of CCR5 and CXCR3 attenuates murine aGVHD through modulating donor-derived T-cell distribution and function, and this might be applicable for aGVHD prophylaxis in clinical settings.<\/jats:p>","DOI":"10.1093\/intimm\/dxae033","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T04:38:40Z","timestamp":1716439120000},"page":"541-552","source":"Crossref","is-referenced-by-count":5,"title":["Blockade of CCR5 and CXCR3 attenuates murine acute graft-versus-host disease through modulating donor-derived T-cell distribution and function"],"prefix":"10.1093","volume":"36","author":[{"given":"Bo","family":"Tang","sequence":"first","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Qin","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Liu","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Miao","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xue","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Dong","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyun","family":"Ren","sequence":"additional","affiliation":[{"name":"Peking University First Hospital Department of Hematology, , Beijing , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2024091014262173300_CIT0001","first-page":"87","article-title":"2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders","author":"Pasquini","year":"2010","journal-title":"Clin Transpl"},{"key":"2024091014262173300_CIT0002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beha.2008.02.006","article-title":"Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity","volume":"21","author":"Johnston","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"2024091014262173300_CIT0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2007.1.62","article-title":"GVHD the nuts and bolts","author":"Weisdorf","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2024091014262173300_CIT0004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/TP.0000000000002836","article-title":"Comparison of tacrolimus and cyclosporine combined with methotrexate for graft versus host disease prophylaxis after allogeneic hematopoietic cell transplantation","volume":"104","author":"Huang","year":"2020","journal-title":"Transplantation"},{"key":"2024091014262173300_CIT0005","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"key":"2024091014262173300_CIT0006","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"2024091014262173300_CIT0007","first-page":"36","article-title":"Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation","volume":"14","author":"Heidenhain","year":"2009","journal-title":"Ann Transplant"},{"key":"2024091014262173300_CIT0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI6642","article-title":"Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease","volume":"104","author":"Murai","year":"1999","journal-title":"J Clin Invest"},{"key":"2024091014262173300_CIT0009","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease","volume":"367","author":"Reshef","year":"2012","journal-title":"N Engl J Med"},{"key":"2024091014262173300_CIT0010","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-472X(03)00198-X","article-title":"Role of CXCR3-induced donor T-cell migration in acute GVHD","volume":"31","author":"Duffner","year":"2003","journal-title":"Exp Hematol"},{"key":"2024091014262173300_CIT0011","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/jid.2014.2","article-title":"CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease","volume":"134","author":"Villarroel","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2024091014262173300_CIT0012","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00011-014-0793-6","article-title":"Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model","volume":"64","author":"Yuan","year":"2015","journal-title":"Inflamm Res"},{"key":"2024091014262173300_CIT0013","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2017.12.010","article-title":"CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model","volume":"94","author":"Miao","year":"2018","journal-title":"Mol Immunol"},{"key":"2024091014262173300_CIT0014","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.180.7.4714","article-title":"Combined CXCR3\/CCR5 blockade attenuates acute and chronic rejection","volume":"180","author":"Schnickel","year":"2008","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0015","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2352-3026(18)30221-7","article-title":"Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)","volume":"6","author":"Bola\u00f1os-Meade","year":"2019","journal-title":"Lancet Haematol"},{"key":"2024091014262173300_CIT0016","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2016-08-735076","article-title":"Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis","volume":"129","author":"Moy","year":"2017","journal-title":"Blood"},{"key":"2024091014262173300_CIT0017","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.4049\/jimmunol.173.9.5467","article-title":"Target antigens determine graft-versus-host disease phenotype","volume":"173","author":"Kaplan","year":"2004","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0018","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00011-016-0974-6","article-title":"CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function","volume":"65","author":"Tang","year":"2016","journal-title":"Inflamm Res"},{"key":"2024091014262173300_CIT0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ni879","article-title":"Peyer\u2019s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction","volume":"4","author":"Murai","year":"2003","journal-title":"Nat Immunol"},{"key":"2024091014262173300_CIT0020","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2009-08-237768","article-title":"Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation","volume":"115","author":"McDermott","year":"2010","journal-title":"Blood"},{"key":"2024091014262173300_CIT0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbmt.2009.05.017","article-title":"CCR5 expression on cells from HLA-matched unrelated marrow donors and graft-versus-host disease","volume":"16","author":"Ma","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024091014262173300_CIT0022","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bjh.13387","article-title":"CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor","volume":"171","author":"Bogunia-Kubik","year":"2015","journal-title":"Br J Haematol"},{"key":"2024091014262173300_CIT0023","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.4049\/jimmunol.181.11.7581","article-title":"A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody","volume":"181","author":"He","year":"2008","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0024","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1182\/blood-2012-01-403196","article-title":"IFN\u03b3R signaling mediates alloreactive T-cell trafficking and GVHD","volume":"120","author":"Choi","year":"2012","journal-title":"Blood"},{"key":"2024091014262173300_CIT0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4049\/jimmunol.173.2.845","article-title":"Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning","volume":"173","author":"Wysocki","year":"2004","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12799","article-title":"Role of lymph node stroma and microenvironment in T cell tolerance","volume":"292","author":"Saxena","year":"2019","journal-title":"Immunol Rev"},{"key":"2024091014262173300_CIT0027","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.it.2021.06.006","article-title":"Lymph node fibroblastic reticular cells steer immune responses","volume":"42","author":"Li","year":"2021","journal-title":"Trends Immunol"},{"key":"2024091014262173300_CIT0028","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/eji.201948368","article-title":"IL-7 derived from lymph node fibroblastic reticular cells is dispensable for naive T cell homeostasis but crucial for central memory T cell survival","volume":"50","author":"Knop","year":"2020","journal-title":"Eur J Immunol"},{"key":"2024091014262173300_CIT0029","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41590-019-0515-x","article-title":"Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling","volume":"20","author":"Brown","year":"2019","journal-title":"Nat Immunol"},{"key":"2024091014262173300_CIT0030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.1402520","article-title":"Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle","volume":"194","author":"Brown","year":"2015","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0031","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.2000914","article-title":"Development and immunological function of lymph node stromal cells","volume":"206","author":"Pikor","year":"2021","journal-title":"J Immunol"},{"key":"2024091014262173300_CIT0032","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","article-title":"CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity","volume":"56","author":"Moreno Ayala","year":"2023","journal-title":"Immunity"},{"key":"2024091014262173300_CIT0033","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intimm\/advance-article-pdf\/doi\/10.1093\/intimm\/dxae033\/58412489\/dxae033.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/36\/10\/541\/59074430\/dxae033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intimm\/article-pdf\/36\/10\/541\/59074430\/dxae033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T10:30:26Z","timestamp":1725964226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intimm\/article\/36\/10\/541\/7680048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxae033","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2256124\/v1","asserted-by":"object"}]},"ISSN":["1460-2377"],"issn-type":[{"value":"1460-2377","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,5,23]]}}}